NEO-201 is an IgG1 mAb that exhibits ADCC and CDC activity in vitro and attenuation of tumor growth in xenograft models.40 The authors demonstrated that ALT-803 significantly enhanced the ADCC mediated by NEO-201 against the highest NEO-201-positive carcinoma cell line (CFPAC-1) in a dose-dependent manner, compared with the vehicle control at both E:T ratios (Fig. 1). This evidence concerns the gene GPT and carcinoma.